TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls” January 11, 2013
TCL Archive Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report July 26, 1985
TCL Archive In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy August 6, 1999
TCL Archive “Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says November 4, 1994
